BeiGene Ownership | Who Owns BeiGene?
BeiGene Ownership Summary
BeiGene is owned by 43.88% institutional investors, 17.79% insiders, and 38.33% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 7.80% of BGNE shares. Capital Group New Perspective Comp is the top mutual fund, with 2.64% of its assets in BeiGene shares.
BGNE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | BeiGene | 43.88% | 17.79% | 38.33% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baker bros. advisors lp | 10.57M | 7.80% | $1.51B |
Capital investors | 7.01M | 5.17% | $1.00B |
Hhlr advisors | 5.18M | 3.82% | $738.59M |
Primecap management co/ca/ | 4.99M | 3.68% | $711.39M |
Baillie gifford | 3.68M | 2.72% | $525.30M |
Temasek (private) | 3.01M | 2.22% | $430.03M |
Price t rowe associates inc /md/ | 2.27M | 1.68% | $324.26M |
Fmr | 1.65M | 1.22% | $235.00M |
Blackrock | 959.19K | 0.71% | $136.85M |
Capital, inc./ca/ | 855.13K | 0.63% | $122.00M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Baker bros. advisors lp | 10.57M | 19.27% | $1.51B |
Hhlr advisors | 5.18M | 18.22% | $738.59M |
Long corridor asset management | 52.62K | 7.11% | $7.51M |
Exome asset management | 33.20K | 4.22% | $4.74M |
Jgp global gestao de recursos ltda. | 9.37K | 3.94% | $1.73B |
Boxer capital | 500.00K | 3.76% | $71.33M |
Nan fung group | 23.02K | 3.50% | $3.28M |
Xy capital | 24.60K | 2.19% | $4.54M |
Temasek (private) | 3.01M | 2.00% | $430.03M |
Affinity asset advisors | 110.00K | 1.81% | $15.69M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 asset management | 381.38K | 0.14% | 381.38K |
Price t rowe associates inc /md/ | 2.27M | 0.04% | 246.73K |
Artisan partners limited partnership | 208.42K | 0.04% | 63.49K |
Van eck associates | 89.04K | 0.02% | 50.15K |
Woodline partners lp | 45.08K | 0.06% | 45.08K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vestal point capital, lp | - | - | -350.00K |
Artal group | 303.37K | 1.10% | -101.41K |
Invesco | 111.31K | 0.00% | -94.85K |
Bank of america corp /de/ | 287.35K | 0.00% | -65.75K |
Pictet asset management sa | 108.83K | 0.02% | -55.49K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Point72 asset management | 381.38K | 0.14% | 381.38K | $54.41M |
Woodline partners lp | 45.08K | 0.06% | 45.08K | $6.43M |
Citigroup | 15.00K | 0.00% | 15.00K | $2.14M |
Susquehanna group, llp | 11.09K | 0.00% | 11.09K | $1.58M |
Driehaus capital management | 8.19K | 0.01% | 8.19K | $1.17M |
Sold Out
Holder | Change |
---|---|
Allworth financial lp | -1.00 |
Central trust | -1.00 |
Financial gravity asset management | -1.00 |
Advisornet financial | -2.00 |
Concourse financial group securities | -3.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 234 | 14.15% | 46,472,316 | -0.63% | 43 | 3.69% | 107 | 17.58% | 84 | 27.27% |
Jun 30, 2024 | 203 | -1.93% | 46,765,610 | 0.79% | 34 | 1.75% | 90 | -29.69% | 65 | 41.30% |
Mar 31, 2024 | 207 | -0.96% | 46,399,493 | 3.32% | 44 | 4.08% | 128 | 37.63% | 46 | -37.84% |
Dec 31, 2023 | 209 | 1.95% | 44,906,761 | -4.78% | 33 | 1.62% | 93 | 5.68% | 74 | 7.25% |
Sep 30, 2023 | 205 | -3.76% | 47,161,473 | 0.33% | 45 | 2.21% | 88 | -2.22% | 69 | -2.82% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Capital Group New Perspective Comp | 2.80M | 2.64% | - |
American Funds New Perspective A | 2.80M | 2.63% | - |
Vanguard PRIMECAP Inv | 2.20M | 2.07% | -80.00K |
Capital Group New Geography Equity Comp | 1.16M | 1.09% | -693.60K |
American Funds New World A | 1.16M | 1.08% | - |
Vanguard Capital Opportunity Inv | 1.08M | 1.02% | 51.00K |
T. Rowe Price Health Sciences | 725.72K | 0.68% | -17.51K |
PRIMECAP Odyssey Aggressive Growth | 704.96K | 0.66% | - |
PRIMECAP Odyssey Growth | 683.73K | 0.64% | 2.30K |
T. Rowe Price International Gr Eq Tr-D | 673.60K | 0.63% | 86.03K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 07, 2025 | Wang Xiaodong | Chair, Scientific Advisory Brd | Sell | $755.81K |
Jan 07, 2025 | Wang Xiaodong | Chair, Scientific Advisory Brd | Sell | $1.01M |
Jan 07, 2025 | Wang Xiaodong | Chair, Scientific Advisory Brd | Sell | $3.38M |
Jan 07, 2025 | Wang Xiaodong | Chair, Scientific Advisory Brd | Sell | $2.00M |
Jan 07, 2025 | Wang Xiaodong | Chair, Scientific Advisory Brd | Sell | $233.12K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 47 |
2024 Q3 | - | 12 |
2024 Q2 | - | 38 |
2024 Q1 | - | 15 |
2023 Q4 | - | 2 |
BGNE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools